Various LncRNA Mechanisms in Gene Regulation Involving miRNAs or RNA-Binding Proteins in Non-Small-Cell Lung Cancer: Main Signaling Pathways and Networks

被引:24
作者
Braga, Eleonora A. [1 ,2 ]
Fridman, Marina V. [3 ]
Burdennyy, Alexey M. [1 ]
Loginov, Vitaly I. [1 ,2 ]
Dmitriev, Alexey A. [4 ]
Pronina, Irina V. [1 ]
Morozov, Sergey G. [1 ]
机构
[1] Inst Gen Pathol & Pathophysiol, Moscow 125315, Russia
[2] Res Ctr Med Genet, Moscow 115522, Russia
[3] Russian Acad Sci, Vavilov Inst Gen Genet, Moscow 119991, Russia
[4] Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow 119991, Russia
关键词
lncRNA; mRNA; miRNA; ceRNA model; RNA-binding protein; hnRNP; EPITHELIAL-MESENCHYMAL TRANSITION; POSTOPERATIVE DISTANT RECURRENCE; POSITIVE FEEDBACK LOOP; LONG NONCODING RNAS; CISPLATIN-RESISTANCE; NSCLC CELLS; KNOCKDOWN SUPPRESSES; TUMOR PROGRESSION; DOWN-REGULATION; PROMOTES;
D O I
10.3390/ijms241713617
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Long non-coding RNAs (lncRNAs) are crucial players in the pathogenesis of non-small-cell lung cancer (NSCLC). A competing binding of lncRNAs and mRNAs with microRNAs (miRNAs) is one of the most common mechanisms of gene regulation by lncRNAs in NSCLC, which has been extensively researched in the last two decades. However, alternative mechanisms that do not depend on miRNAs have also been reported. Among them, the most intriguing mechanism is mediated by RNA-binding proteins (RBPs) such as IGF2BP1/2/3, YTHDF1, HuR, and FBL, which increase the stability of target mRNAs. IGF2BP2 and YTHDF1 may also be involved in m6A modification of lncRNAs or target mRNAs. Some lncRNAs, such as DLGAP1-AS2, MALAT1, MNX1-AS1, and SNHG12, are involved in several mechanisms depending on the target: lncRNA/miRNA/mRNA interactome and through RBP. The target protein sets selected here were then analyzed using the DAVID database to identify the pathways overrepresented by KEGG, Wikipathways, and the Reactome pathway. Using the STRING website, we assessed interactions between the target proteins and built networks. Our analysis revealed that the JAK-STAT and Hippo signaling pathways, cytokine pathways, the VEGFA-VEGFR2 pathway, mechanisms of cell cycle regulation, and neovascularization are the most relevant to the effect of lncRNA on NSCLC.
引用
收藏
页数:34
相关论文
共 175 条
[31]   Long non-coding RNA LINC00243 promotes proliferation and glycolysis in non-small cell lung cancer cells by positively regulating PDK4 through sponging miR-507 [J].
Feng, Xuegang ;
Yang, Shengsheng .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 2020, 463 (1-2) :127-136
[32]   A promoter-level mammalian expression atlas [J].
Forrest, Alistair R. R. ;
Kawaji, Hideya ;
Rehli, Michael ;
Baillie, J. Kenneth ;
de Hoon, Michiel J. L. ;
Haberle, Vanja ;
Lassmann, Timo ;
Kulakovskiy, Ivan V. ;
Lizio, Marina ;
Itoh, Masayoshi ;
Andersson, Robin ;
Mungall, Christopher J. ;
Meehan, Terrence F. ;
Schmeier, Sebastian ;
Bertin, Nicolas ;
Jorgensen, Mette ;
Dimont, Emmanuel ;
Arner, Erik ;
Schmidl, Christian ;
Schaefer, Ulf ;
Medvedeva, Yulia A. ;
Plessy, Charles ;
Vitezic, Morana ;
Severin, Jessica ;
Semple, Colin A. ;
Ishizu, Yuri ;
Young, Robert S. ;
Francescatto, Margherita ;
Alam, Intikhab ;
Albanese, Davide ;
Altschuler, Gabriel M. ;
Arakawa, Takahiro ;
Archer, John A. C. ;
Arner, Peter ;
Babina, Magda ;
Rennie, Sarah ;
Balwierz, Piotr J. ;
Beckhouse, Anthony G. ;
Pradhan-Bhatt, Swati ;
Blake, Judith A. ;
Blumenthal, Antje ;
Bodega, Beatrice ;
Bonetti, Alessandro ;
Briggs, James ;
Brombacher, Frank ;
Burroughs, A. Maxwell ;
Califano, Andrea ;
Cannistraci, Carlo V. ;
Carbajo, Daniel ;
Chen, Yun .
NATURE, 2014, 507 (7493) :462-+
[33]   LncRNA NBR2 inhibits EMT progression by regulating Notch1 pathway in NSCLC [J].
Gao, Y-P ;
Li, Y. ;
Li, H-J ;
Zhao, B. .
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (18) :7950-7958
[34]   LncRNA SNHG1 contributes to the cisplatin resistance and progression of NSCLC via miR-330-5p/DCLK1 axis [J].
Ge, Peng ;
Cao, Lei ;
Zheng, Ming ;
Yao, Yuejuan ;
Wang, Wei ;
Chen, Xin .
EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2021, 120
[35]   lncRNA FOXD2-AS1 confers cisplatin resistance of non-small-cell lung cancer via regulation of miR 185-5p-SIX1 axis [J].
Ge, Peng ;
Cao, Lei ;
Yao, Yue-Juan ;
Jing, Rui-Jun ;
Wang, Wei ;
Li, Han-Jie .
ONCOTARGETS AND THERAPY, 2019, 12 :6105-6117
[36]  
Geng WT, 2022, AM J TRANSL RES, V14, P3003
[37]   Architecture of the human regulatory network derived from ENCODE data [J].
Gerstein, Mark B. ;
Kundaje, Anshul ;
Hariharan, Manoj ;
Landt, Stephen G. ;
Yan, Koon-Kiu ;
Cheng, Chao ;
Mu, Xinmeng Jasmine ;
Khurana, Ekta ;
Rozowsky, Joel ;
Alexander, Roger ;
Min, Renqiang ;
Alves, Pedro ;
Abyzov, Alexej ;
Addleman, Nick ;
Bhardwaj, Nitin ;
Boyle, Alan P. ;
Cayting, Philip ;
Charos, Alexandra ;
Chen, David Z. ;
Cheng, Yong ;
Clarke, Declan ;
Eastman, Catharine ;
Euskirchen, Ghia ;
Frietze, Seth ;
Fu, Yao ;
Gertz, Jason ;
Grubert, Fabian ;
Harmanci, Arif ;
Jain, Preti ;
Kasowski, Maya ;
Lacroute, Phil ;
Leng, Jing ;
Lian, Jin ;
Monahan, Hannah ;
O'Geen, Henriette ;
Ouyang, Zhengqing ;
Partridge, E. Christopher ;
Patacsil, Dorrelyn ;
Pauli, Florencia ;
Raha, Debasish ;
Ramirez, Lucia ;
Reddy, Timothy E. ;
Reed, Brian ;
Shi, Minyi ;
Slifer, Teri ;
Wang, Jing ;
Wu, Linfeng ;
Yang, Xinqiong ;
Yip, Kevin Y. ;
Zilberman-Schapira, Gili .
NATURE, 2012, 489 (7414) :91-100
[38]   The hnRNP family: insights into their role in health and disease [J].
Geuens, Thomas ;
Bouhy, Delphine ;
Timmerman, Vincent .
HUMAN GENETICS, 2016, 135 (08) :851-867
[39]   LncRNAs in Non-Small-Cell Lung Cancer [J].
Ginn, Lucy ;
Shi, Lei ;
La Montagna, Manuela ;
Garofalo, Michela .
NON-CODING RNA, 2020, 6 (03)
[40]   Long non-coding RNA FENDRR attenuates the sternness of non-small cell lung cancer cells via decreasing multidrug resistance gene 1 (MDR1) expression through competitively binding with RNA binding protein HuR [J].
Gong, Fangchao ;
Dong, Dong ;
Zhang, Ting ;
Xu, Weiling .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2019, 853 :345-352